Law360, New York (February 13, 2012, 8:04 PM ET) -- Facebook Inc., Google Inc., and others lodged amicus briefs Friday on behalf of HemCon Medical Technologies Inc. ahead of an en banc rehearing of a Federal Circuit panel's decision that changed the way intervening rights apply during patent re-examinations.
A three-judge panel's controversial September ruling in Marine Polymer Technologies Inc.’s case against HemCon held that intervening rights for an accused infringer apply when a patentholder merely makes an argument during re-examination that affect the scope of the claims.
But on Jan. 20, the Federal Circuit vacated...
Facebook, Others Weigh In On Fed. Circ. Intervening Rights Case
To view the full article, take a free trial now.
